Biomarker analysis and updated clinical outcomes: Neoadjuvant systemic treatment (NST) with nivolumab (nivo) and relatlimab (rela) in surgically resectable melanoma Meeting Abstract
| Authors: | Burton, E. M.; Wani, K. M.; Milton, D. R.; Segura, R. L.; Tetzlaff, M.; Ross, M. I.; Postow, M. A.; Glitza, I. C.; Wong, M. K. K.; Diab, A.; Gershenwald, J. E.; Patel, S. P.; McQuade, J. L.; Prieto, V. G.; Ariyan, C. E.; Lazar, A. J.; Wargo, J. A.; Tawbi, H. A.; Amaria, R. N. |
| Abstract Title: | Biomarker analysis and updated clinical outcomes: Neoadjuvant systemic treatment (NST) with nivolumab (nivo) and relatlimab (rela) in surgically resectable melanoma |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557402271 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.9587 |
| Notes: | Meeting Abstract: 9587 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
